PAVmed to post Q3 non-GAAP adjusted net loss of $1.2M
at seekingalpha.com (Fri, 13-Nov 9:24 AM)
PAVmed Reports Medicare Reimbursement for Lucid EsoGuard Tests
at www.tipranks.com (Fri, 13-Nov 8:29 AM)
PAVmed Non-GAAP EPS of -$0.19 beats by $0.47
at seekingalpha.com (Fri, 13-Nov 8:08 AM)
Here are the major earnings before the open Friday
at seekingalpha.com (Thu, 12-Nov 6:00 PM)
PAVmed’s Lucid subsidiary moves closer to broader Medicare billing for EsoGuard and EsoCheck
Market Chameleon (Tue, 22-Sep 11:48 AM)
